A pilot study to assess the efficacy and safety of Heliox inhalation therapy for resuscitation to preterm infants.
Phase 3
- Conditions
- preterm infants
- Registration Number
- JPRN-UMIN000015061
- Lead Sponsor
- agano Children's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
(1) infants who was suspected severe congenital heart disease before birth (2) infants who was suspected chromosomal abnormality before birth (3) infants who was suspected multiple malformation before birth (4) infants who was suspected severe surgical disease before birth (5)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method intubation rate within the first 7 days after birth
- Secondary Outcome Measures
Name Time Method efficacy(duration of ventilator support,CPAP, and oxygen inhalation, length of NICU stay) safety(mortality, incidence of adverse ivents)